免疫組織化學市場規模、佔有率、成長分析（按產品、應用、最終用戶、地區）- 2025 年至 2032 年產業預測

2023 年全球免疫組織化學市場規模價值 32.4 億美元，預計將從 2024 年的 37.1 億美元成長到 2032 年的 110.5 億美元，預測期內（2025-2032 年）的複合年成長率為 14.6%。

由於慢性病盛行率的上升和對創新診斷技術的大量投資，全球免疫組織化學市場預計將顯著成長。免疫組織化學在藥物發現和開發中的應用日益廣泛，為該領域的供應商創造了更多的商機。此外，伴隨診斷的日益普及預計將隨著診斷技術的進步而產生新的商機，從而刺激需求。然而，熟練專業人員短缺、設備成本高以及誤報風險等挑戰可能會阻礙市場成長。然而，對早期診斷的迫切需求和對先進診斷選擇的日益成長的認知預計將為免疫組織化學提供者創造有利條件，為持續的市場擴張鋪平道路。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

免疫組織化學市場規模：依產品及複合年成長率（2025-2032）

• 市場概覽
• 抗體
  • 一抗
  • 二抗
• 試劑
  • 阻斷試劑
  • 呈色受質
  • 穩定劑
  • 緩衝
  • 檢測試劑套件
• 裝置
  • 玻片染色系統
  • 組織微陣列
  • 自動 IHC 裝置
  • 手動染色系統
• 軟體
  • 影像分析軟體
  • 工作流程管理工具

免疫組織化學市場規模：依應用與複合年成長率（2025-2032）

• 市場概覽
• 診斷
• 調查
• 法醫學應用

免疫組織化學市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和診斷實驗室
• 學術研究所
• 製藥和生物技術公司
• 合約研究組織（CRO）
• 法醫學研究所

免疫組織化學市場規模：按地區及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• F. Hoffmann-La Roche Ltd-Switzerland
• Agilent Technologies, Inc.-USA
• Thermo Fisher Scientific Inc.-USA
• Merck KGaA-Germany
• Abcam PLC-UK
• Bio-Rad Laboratories, Inc.-USA
• PerkinElmer, Inc.-USA
• Cell Signaling Technology, Inc.-USA
• Bio SB-USA
• Danaher Corporation-USA
• Takara Bio Inc.-Japan
• Leica Biosystems（Danaher Corporation）-Germany
• Sakura Finetek USA, Inc.-USA
• Biocare Medical, LLC-USA
• Biogenex Laboratories-USA
• Miltenyi Biotec-Germany
• Enzo Life Sciences, Inc.-USA
• Diagnostic Biosystems-USA
• Bio-Techne Corporation-USA

結論和建議

Global Immunohistochemistry Market size was valued at USD 3.24 billion in 2023 and is poised to grow from USD 3.71 billion in 2024 to USD 11.05 billion by 2032, growing at a CAGR of 14.6% during the forecast period (2025-2032).

The global immunohistochemistry market is poised for significant growth, driven by the rising prevalence of chronic diseases and substantial investments in innovative diagnostic technologies. Increased utilization of immunohistochemistry in drug discovery and development further enhances business potential for providers in this sector. The growing adoption of companion diagnostics is anticipated to generate additional opportunities, alongside advancements in diagnostic technologies that will fuel demand. However, challenges such as a shortage of skilled professionals, high equipment costs, and the risk of false positives may impede market growth. Nevertheless, the urgent need for early diagnosis and heightened awareness of advanced diagnostic options are expected to create favorable conditions for immunohistochemistry providers, paving the way for sustained market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segments Analysis

Global Immunohistochemistry Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Antibodies, Reagents, Equipment and Software. Based on Application, the market is segmented into Diagnostics, Research and Forensic Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunohistochemistry Market

The global immunohistochemistry market is significantly influenced by the rising incidence of chronic diseases, which underscores the essential role of immunohistochemistry in diagnostics. As the prevalence of these diseases continues to escalate globally, there is a corresponding increase in the demand for immunohistochemistry products and technologies. This growing need for accurate and efficient diagnostic tools to identify and monitor chronic conditions is poised to propel the market forward. Consequently, the increasing focus on improving diagnostic capabilities and patient outcomes through advanced immunohistochemistry solutions is anticipated to further drive market growth in the coming years.

Restraints in the Global Immunohistochemistry Market

The global immunohistochemistry market faces significant restraints due to the high costs associated with its products and technologies, which often involve sophisticated methodologies and considerable investment in research and development. These elevated expenses can hinder adoption among institutions with constrained budgets, ultimately impeding market growth. As a result, facilities with limited financial resources may be unable to integrate these advanced tools into their operations, restricting overall access to immunohistochemistry technologies. Consequently, the financial burden poses a challenge, preventing many healthcare and research establishments from fully benefiting from the advancements available in the immunohistochemistry sector.

Market Trends of the Global Immunohistochemistry Market

The Global Immunohistochemistry market is experiencing a transformative trend towards automation, driven by advancements in technology and the increasing demand for efficient diagnostic solutions. Automated immunohistochemistry systems are anticipated to enhance precision and reduce labor costs, presenting lucrative opportunities for market players. The integration of artificial intelligence into these systems is poised to revolutionize workflows, enabling faster and more accurate staining processes. As laboratories seek to optimize their operations amidst growing workloads, the adoption of automated solutions will not only streamline procedures but also elevate diagnostic capabilities, thereby positioning themselves favorably in an increasingly competitive healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Immunohistochemistry Market Size by Product & CAGR (2025-2032)

• Market Overview
• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Blocking Reagents
  • Chromogenic Substrates
  • Fixatives
  • Buffers
  • Detection Kits
• Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Automated IHC Instruments
  • Manual Staining Systems
• Software
  • Image Analysis Software
  • Workflow Management Tools

Global Immunohistochemistry Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Research
• Forensic Applications

Global Immunohistochemistry Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Forensic Laboratories

Global Immunohistochemistry Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam PLC - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems (Danaher Corporation) - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenex Laboratories - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostic Biosystems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations